Showing results (3521-3530 of 5,147) with videos related to
Sort By:
Pageof 515
Vox Sanguinis|January 1, 1994
Removal and inactivation of hepatitis A virus (HAV) during processing of factor VIII concentratesJ Hamman, J Zou, B HorowitzVox Sanguinis|January 1, 1994
FDA perspective on and response to the risk of hepatitis A from blood productsW FrickeVox Sanguinis|January 1, 1994
The natural history of hepatitis A: the potential for transmission by transfusion of blood or blood productsS M LemonVox Sanguinis|December 5, 2023
Virtual platelet cross-matching as transfusion management for patients with immune platelet refractorinessCarolina Bonet-Bub, Bruna Paccola Blanco, Thais Carvalho de Oliveira, et al.Vox Sanguinis|December 5, 2023
Challenges associated with access to plasma-derived medicinal products in low middle-income and low-income countriesMagdy El Ekiaby, Saliou Diop, Emna Gouider, et al.Vox Sanguinis|November 24, 2023
Effects of plasmapheresis frequency on health status and exercise performance in men: A randomized controlled trialAlexandre Mortier, Jina Khoudary, Sophie van Dooslaer de Ten Ryen, et al.Vox Sanguinis|December 29, 2023
Notification and follow-up of blood donors reactive for transfusion-transmitted infections: A narrative review of the literature from IndiaRahul Chaurasia, Gopal Kumar Patidar, Hem Chandra Pandey, et al.Vox Sanguinis|December 29, 2023
Using competition for plasma donor recruitment and retention: An Australian university case studyJack Bryant, Torres Woolley, Tarun Sen Gupta, et al.Vox Sanguinis|December 28, 2023
Implementation of amotosalen plus ultraviolet A-mediated pathogen reduction for all platelet concentrates in France: Impact on the risk of transfusion-transmitted infectionsPascale Richard, Elodie Pouchol, Imad Sandid, et al.Vox Sanguinis|March 25, 2024
Determining the impact of current Canadian stem cell registry policy on donor availability via dynamic registry simulationJohn T Blake, Kathy Ganz, Matthew Seftel, et al.Pageof 515